PHILA SASENBURY: Open Payments
NPI 1336669043 · ELMIRA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,187 in 52 payments from 13 companies in 2025. Trend: 2023 $289 · 2024 $662 · 2025 $1,187
Food & beverage: $1,098Education: $89
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 16 | $278 |
| AstraZeneca Pharmaceuticals LP | 9 | $241 |
| Regeneron Healthcare Solutions, Inc. | 5 | $136 |
| Verona Pharma, Inc. | 4 | $100 |
| SANOFI-AVENTIS U.S. LLC | 1 | $89 |
| Insmed, Inc. | 5 | $82 |
| Grifols USA, LLC | 3 | $80 |
| Amgen Inc. | 3 | $60 |
| Lilly USA, LLC | 2 | $31 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, AIRSUPRA, TEZSPIRE, Ohtuvayre, Arikayce, Prolastin-C Liquid.
Industry payments across NY — which companies pay providers there.
